Free Trial
NASDAQ:ENSG

The Ensign Group Q2 2025 Earnings Report

The Ensign Group logo
$138.85 -1.00 (-0.72%)
Closing price 04:00 PM Eastern
Extended Trading
$139.08 +0.23 (+0.16%)
As of 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Ensign Group EPS Results

Actual EPS
N/A
Consensus EPS
$1.54
Beat/Miss
N/A
One Year Ago EPS
N/A

The Ensign Group Revenue Results

Actual Revenue
N/A
Expected Revenue
$1.22 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

The Ensign Group Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Friday, July 25, 2025
Conference Call Time
1:00PM ET

Conference Call Resources

The Ensign Group Earnings Headlines

How Is The Market Feeling About Ensign Group?
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
ENSG - Ensign Group Inc Key Metrics - Morningstar
The Ensign Group Continues Growth in Idaho
See More The Ensign Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like The Ensign Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on The Ensign Group and other key companies, straight to your email.

About The Ensign Group

The Ensign Group (NASDAQ:ENSG) (NASDAQ: ENSG) is a leading post‐acute healthcare services provider headquartered in Mission Viejo, California. Since its founding in 1999 by Robert “Bob” Holmes, the company has grown through a combination of strategic acquisitions and organic development to operate a network of skilled nursing facilities, assisted living communities, home health agencies and outpatient therapy centers. Its mission centers on delivering high‐quality, patient‐centered care across the continuum of post‐acute services.

At the core of The Ensign Group’s offerings is its operator‐centric model, which empowers local management teams to make clinical and operational decisions that best serve residents and patients. Through in‐house rehabilitation services—including physical, occupational and speech therapy—the company emphasizes seamless transitions from hospital to home and works to reduce rehospitalization rates. This comprehensive approach supports a broad range of patient needs, from short‐term recovery and rehabilitative therapy to long‐term skilled nursing and assisted living care.

Operating throughout the United States, The Ensign Group serves diverse communities with an emphasis on maintaining high clinical standards and fostering positive outcomes. Its facilities are designed to provide comfortable, home‐like environments, while specialized teams focus on individualized care plans. The company’s outpatient therapy and home health divisions further extend its reach, delivering tailored treatment in community and home settings.

Under the leadership of CEO Robert Holmes, The Ensign Group has cultivated a culture of clinical excellence and operational accountability. Senior management combines deep industry experience with a commitment to continuous improvement, guiding the company as it advances its integrated care model and expands its footprint in the post‐acute healthcare marketplace.

View The Ensign Group Profile

More Earnings Resources from MarketBeat